FluoGuide A/S — Investor Relations & Filings

FluoGuide A/S is a clinical-stage biotechnology company specializing in precision cancer surgery. The company develops products designed to make cancer cells fluorescent during surgical procedures, enabling surgeons to more accurately distinguish and remove malignant tissue from healthy tissue. Its lead product, FG001, is a fluorescent agent that targets the urokinase-type plasminogen activator receptor (uPAR), which is highly expressed in most solid tumors. The primary goal of this technology is to improve surgical outcomes for cancer patients by increasing the precision of tumor removal, thereby reducing cancer recurrence and minimizing surgical complications.